Design of oral solid dosage forms containing Irbesartan nanoparticles: Solid-formulation and intestinal absorption of Irbesartan

○Misa Minami

[29P01-270S] Design of oral solid dosage forms containing Irbesartan nanoparticles: Solid-formulation and intestinal absorption of Irbesartan

○Misa Minami¹, Masaki Watanabe¹, Ayari Ike¹, Yurisa Shimomae¹, Hiroko Otake¹, Noriaki Nagai¹ (1. Pharm, Kindai Univ.)

A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.

Presentation information

[29P01] ターゲティング/がん治療DDS
製剤の設計・製造（固形・注射剤・液剤）/新規剤形

[29P01-270S] Design of oral solid dosage forms containing Irbesartan nanoparticles: Solid-formulation and intestinal absorption of Irbesartan

Password

Presentation information

[29P01] ターゲティング/がん治療DDS製剤の設計・製造（固形・注射剤・液剤）/新規剤形

[29P01-270S] Design of oral solid dosage forms containing Irbesartan nanoparticles: Solid-formulation and intestinal absorption of Irbesartan

Password

[29P01] ターゲティング/がん治療DDS
製剤の設計・製造（固形・注射剤・液剤）/新規剤形